Jin Yang Baek

2.6k total citations
78 papers, 1.8k citations indexed

About

Jin Yang Baek is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Jin Yang Baek has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 32 papers in Epidemiology and 19 papers in Microbiology. Recurrent topics in Jin Yang Baek's work include Pneumonia and Respiratory Infections (26 papers), Antimicrobial Resistance in Staphylococcus (21 papers) and Bacterial Infections and Vaccines (18 papers). Jin Yang Baek is often cited by papers focused on Pneumonia and Respiratory Infections (26 papers), Antimicrobial Resistance in Staphylococcus (21 papers) and Bacterial Infections and Vaccines (18 papers). Jin Yang Baek collaborates with scholars based in South Korea, Thailand and Malaysia. Jin Yang Baek's co-authors include Kwan Soo Ko, Kyong Ran Peck, Doo Ryeon Chung, Jae‐Hoon Song, Cheol‐In Kang, Kim Ys, Jae‐Hoon Song, Sun Young Cho, Won Sup Oh and Young Eun Ha and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Jin Yang Baek

75 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jin Yang Baek South Korea	21	841	737	357	339	287	78	1.8k
Shima Mahmoudi Iran	24	990 1.2×	627 0.9×	246 0.7×	114 0.3×	252 0.9×	163	2.0k
Nobuyuki Shimono Japan	21	620 0.7×	736 1.0×	380 1.1×	200 0.6×	358 1.2×	97	1.8k
Kaihu Yao China	27	548 0.7×	1.3k 1.7×	318 0.9×	729 2.2×	174 0.6×	144	2.0k
G. Młynarczyk Poland	21	502 0.6×	469 0.6×	290 0.8×	114 0.3×	267 0.9×	176	1.4k
Thaís Guimarães Brazil	26	995 1.2×	928 1.3×	188 0.5×	88 0.3×	520 1.8×	96	2.1k
Vikas Manchanda India	22	395 0.5×	559 0.8×	340 1.0×	177 0.5×	794 2.8×	74	1.8k
Wadha Alfouzan Kuwait	23	899 1.1×	728 1.0×	220 0.6×	94 0.3×	316 1.1×	92	1.6k
Grace M. Thorne United States	24	1.1k 1.3×	492 0.7×	435 1.2×	237 0.7×	235 0.8×	62	2.1k
Yonit Wiener‐Well Israel	17	582 0.7×	628 0.9×	327 0.9×	60 0.2×	373 1.3×	60	1.6k
Rosemary C. She United States	23	418 0.5×	564 0.8×	207 0.6×	150 0.4×	233 0.8×	85	1.6k

Countries citing papers authored by Jin Yang Baek

Since Specialization

Citations

This map shows the geographic impact of Jin Yang Baek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Yang Baek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Yang Baek more than expected).

Fields of papers citing papers by Jin Yang Baek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Yang Baek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Yang Baek. The network helps show where Jin Yang Baek may publish in the future.

Co-authorship network of co-authors of Jin Yang Baek

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Yang Baek. A scholar is included among the top collaborators of Jin Yang Baek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Yang Baek. Jin Yang Baek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Ho Jun, Jin Yang Baek, Young J. Lee, et al.. (2025). Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: A longitudinal observation from primary to updated booster vaccine cohorts. Journal of Infection and Public Health. 18(7). 102794–102794. 1 indexed citations

Baek, Jin Yang, Jae‐Hoon Ko, Sun Young Cho, et al.. (2024). Antimicrobial activity of ceftazidime-avibactam against KPC-2-producing Enterobacterales: a cross-combination and dose-escalation titration study with relebactam and vaborbactam. Microbiology Spectrum. 12(6). e0034424–e0034424. 2 indexed citations

Song, Kyoung‐Ho, Kyoung Hwa Lee, Jin Yang Baek, et al.. (2024). Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection. Vaccine. 42(19). 3953–3960. 3 indexed citations

Baek, Jin Yang, Jae‐Hoon Ko, Kyungmin Huh, et al.. (2024). Clinical and microbiological analyses of colistin-resistant strains among carbapenem-resistant Enterobacter cloacae complex clinical isolates. Microbiology Spectrum. 13(2). e0160424–e0160424. 2 indexed citations

Baek, Jin Yang, et al.. (2023). Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID‐19 endemicity. Journal of Medical Virology. 95(12). e29285–e29285. 5 indexed citations

Baek, Jin Yang, Kyungmin Huh, Sun Young Cho, et al.. (2023). Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023. Journal of Korean Medical Science. 38(27). e205–e205. 1 indexed citations

Baek, Jin Yang, Jae‐Hoon Ko, Sun Young Cho, et al.. (2023). Extensively drug-resistant Enterobacter ludwigii co-harbouring MCR-9 and a multicopy of blaIMP-1 in South Korea. Journal of Global Antimicrobial Resistance. 36. 217–222. 3 indexed citations

Lee, Kyo Won, Jin Yang Baek, Seongman Bae, et al.. (2023). Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine. American Journal of Transplantation. 23(4). 565–572. 11 indexed citations

Ko, Jae‐Hoon, Jin Yang Baek, Kyungmin Huh, et al.. (2023). Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant. Journal of Korean Medical Science. 38(37). e292–e292. 3 indexed citations

10.

Baek, Jin Yang, Areum Shin, Kyung-Ran Kim, et al.. (2023). Susceptibility to Fosfomycin and Nitrofurantoin of ESBL-Positive Escherichia coli and Klebsiella pneumoniae Isolated From Urine of Pediatric Patients. Journal of Korean Medical Science. 38(48). e361–e361. 4 indexed citations

11.

Ko, Jae‐Hoon, Soyoung Ha, Eliel Nham, et al.. (2022). Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19. Yonsei Medical Journal. 63(5). 430–430. 7 indexed citations

12.

Ko, Jae‐Hoon, Kyong Ran Peck, Jin Yang Baek, et al.. (2021). A COVID-19 Exposure at a Dental Clinic Where Healthcare Workers Routinely Use Particulate Filtering Respirators. International Journal of Environmental Research and Public Health. 18(12). 6481–6481. 4 indexed citations

13.

Park, Ga Eun, Jae‐Hoon Ko, Sun Young Cho, et al.. (2021). Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae. Antibiotics. 10(4). 469–469. 3 indexed citations

14.

Baek, Jin Yang, Juyoun Shin, Yeun‐Jun Chung, et al.. (2021). Genome-Wide Analysis of the Temporal Genetic Changes in Streptococcus pneumoniae Isolates of Genotype ST320 and Serotype 19A from South Korea. Microorganisms. 9(4). 795–795.

15.

Ko, Jae‐Hoon, Eun‐Jeong Joo, Su‐Jin Park, et al.. (2020). Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients. Journal of Clinical Medicine. 9(7). 2268–2268. 79 indexed citations

16.

Lee, Gi Yong, et al.. (2018). Adaptations of Vancomycin-Intermediate Sequence Type 72 Methicillin-Resistant Staphylococcus aureus for Daptomycin Nonsusceptibility. Microbial Drug Resistance. 24(10). 1489–1496. 2 indexed citations

17.

Joo, Eun‐Jeong, Doo Ryeon Chung, Kim Ys, et al.. (2017). Emergence of Community-Genotype Methicillin-ResistantStaphylococcus aureusin Korean Hospitals: Clinical Characteristics of Nosocomial Infections by Community-Genotype Strain. Infection and Chemotherapy. 49(2). 109–109. 15 indexed citations

18.

Ko, Jae‐Hoon, Marcel A. Müller, Hyeri Seok, et al.. (2017). Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests. European Journal of Clinical Microbiology & Infectious Diseases. 36(11). 2179–2186. 19 indexed citations

19.

Chung, Doo Ryeon, Jin Yang Baek, Kim Ys, et al.. (2016). Decreasing prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus among blood isolates in Korean hospitals. Diagnostic Microbiology and Infectious Disease. 86(4). 464–466. 3 indexed citations

20.

Ko, Kwan Soo, et al.. (2006). Screening of Essential Genes in Staphylococcus aureus N315 Using Comparative Genomics and Allelic Replacement Mutagenesis. Journal of Microbiology and Biotechnology. 16(4). 623–632. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact